Get the Stockscreener App
303.01
1.71%
5.08
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $303.01, with a volume of 3.08M.
It is up +1.71% in the last 24 hours and up +10.26% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$297.93
Open:
$299.23
24h Volume:
3.08M
Relative Volume:
0.89
Market Cap:
$162.55B
Revenue:
$33.42B
Net Income/Loss:
$4.09B
P/E Ratio:
40.13
EPS:
7.55
Net Cash Flow:
$10.39B
1W Performance:
+4.07%
1M Performance:
+10.26%
6M Performance:
-7.94%
1Y Performance:
+6.90%
1-Day Range:
$297.19
$305.33
1-Week Range:
$289.00
$305.33
52-Week Range:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
303.01 | 162.55B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
873.68 | 830.35B | 45.04B | 10.59B | 414.30M | 11.71 |
|
NVO
Novo Nordisk Adr
|
88.08 | 390.99B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
ABBV
Abbvie Inc
|
202.08 | 356.74B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
162.30 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
MRK
Merck Co Inc
|
89.50 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Cordatus Wealth Management LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by JLB & Associates Inc. - MarketBeat
Amgen's EVP David Reese sells $10.2 million in stock By Investing.com - Investing.com Australia
Mattern Capital Management LLC Sells 908 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Nicholson Wealth Management Group LLC Acquires 1,855 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Compass Capital Corp MA ADV Acquires New Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Advyzon Investment Management LLC Invests $232,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen EVP Esteban Santos sells $2.55 million in stock - Investing.com India
Amgen's EVP David Reese sells $10.2 million in stock - Investing.com
Amgen Executives Sell Shares Worth Over $12 Million - TradingView
Venturi Wealth Management LLC Boosts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - MSN
Derek Miller Takes Money Off The Table, Sells $593K In Amgen Stock - Benzinga
Amgen Inc. (NASDAQ:AMGN) is Hussman Strategic Advisors Inc.'s 9th Largest Position - MarketBeat
ING Groep NV Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cell Therapy Market Is Booming So Rapidly with Forecast by 2032 | Bristol Myers Squibb Company, Amgen, Johnson - EIN News
Teva/Alvotech follow Amgen in launching biosimilar for J&J’s Stelara - Seeking Alpha
Handelsbanken Fonder AB Sells 1,545 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
First Bank & Trust Lowers Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara -February 21, 2025 at 06:27 am EST - Marketscreener.com
There May Be Some Bright Spots In Amgen's (NASDAQ:AMGN) Earnings - Yahoo Finance
Ieq Capital LLC Reduces Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Americana Partners LLC Sells 888 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen SVP Derek Miller sells $593,933 in stock - Investing.com India
Truist Financial Corp Trims Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Acquires 10,797 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Principal Financial Group Inc. Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bernstein cuts Amgen stock target to $350, maintains Outperform - Investing.com India
ICICI Prudential Asset Management Co Ltd Acquires 16,985 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bernstein Adjusts Amgen Price Target to $350 From $380, Maintains Outperform Rating - Marketscreener.com
Alberta Investment Management Corp Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Hudson Value Partners LLC - MarketBeat
Convergence Investment Partners LLC Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bryn Mawr Capital Management LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Private Advisor Group LLC Sells 5,009 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Braun Stacey Associates Inc. Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Argus Cuts Price Target on Amgen to $330 From $360, Maintains Buy Rating -February 19, 2025 at 01:38 pm EST - Marketscreener.com
Looking Into Amgen's Recent Short Interest - Benzinga
Wilkinson Global Asset Management LLC Sells 6,077 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Northcape Wealth Management LLC Has $676,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
New York State Common Retirement Fund Grows Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
5,191 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Palacios Wealth Management LLC - MarketBeat
Chevy Chase Trust Holdings LLC Sells 6,084 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
New York State Teachers Retirement System Has $121.33 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Coho Partners Ltd. - MarketBeat
Amgen Inc. (AMGN): A Bull Case Theory - MSN
Empower Advisory Group LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Valley Wealth Managers Inc. Purchases 3,306 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Want Decades of Passive Income? Buy This ETF and Hold It Forever. - The Motley Fool
Mraz Amerine & Associates Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
D.A. Davidson & CO. Purchases 6,507 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amgen Inc Stock (AMGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations |
Feb 19 '25 |
Sale |
292.84 |
8,711 |
2,550,903 |
71,546 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 19 '25 |
Option Exercise |
156.35 |
8,711 |
1,361,965 |
70,858 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 21 '25 |
Sale |
304.44 |
25,225 |
7,679,524 |
36,922 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 19 '25 |
Sale |
293.22 |
8,711 |
2,554,224 |
62,147 |
1.54%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):